SAN DIEGO, Oct. 4, 2017 /PRNewswire/ -- Dthera Sciences (OTCQB:DTHR), a digital therapeutics company focused on developing innovative digital quality of life therapies for neurodegenerative diseases ...
NEW YORK, Sept. 11, 2025 /PRNewswire/ -- CurePSP, the leading research and advocacy nonprofit organization for progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system ...
NEW YORK, Aug. 22, 2024 /PRNewswire/ -- CurePSP has designated Barrow Neurological Institute, Cedars-Sinai Medical Center, the University of British Columbia and the University of Alberta as CurePSP ...
NEW YORK, Jan. 31, 2023 /PRNewswire/ -- CurePSP has awarded a $90,000 grant for the pre-clinical and clinical development of a high-affinity neuroimaging agent to visualize tau deposits specifically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback